Want to join the conversation?
$FITB 2Q15 Q&A: Erika of BoA asked about expenses. Tayfun explains that FITB continues to optimize expenses; at the same time, they are going to continue their investments in risk and compliance infrastructure. At this point, they are not giving any guidance for 2016.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?